<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2023-09-13" version="224" xmlns="http://uniprot.org/uniprot">
  <accession>P01160</accession>
  <accession>Q13766</accession>
  <accession>Q5JZE1</accession>
  <name>ANF_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="59">Natriuretic peptides A</fullName>
    </recommendedName>
    <alternativeName>
      <fullName evidence="53">Atrial natriuretic factor prohormone</fullName>
      <shortName evidence="53">proANF</shortName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="47">Atrial natriuretic peptide prohormone</fullName>
      <shortName evidence="47">preproANP</shortName>
      <shortName evidence="59">proANP</shortName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="50">Atriopeptigen</fullName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="54">Cardiodilatin</fullName>
      <shortName evidence="54">CDD</shortName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="54">preproCDD-ANF</fullName>
    </alternativeName>
    <component>
      <recommendedName>
        <fullName evidence="57">Long-acting natriuretic peptide</fullName>
        <shortName evidence="57">LANP</shortName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="59">Long-acting natriuretic hormone</fullName>
        <shortName evidence="59">LANH</shortName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="46">Pro atrial natriuretic factor 1-30</fullName>
        <shortName evidence="46">proANF 1-30</shortName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="59">Pro atrial natriuretic peptide 1-30</fullName>
        <shortName evidence="59">proANP 1-30</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="57">Vessel dilator</fullName>
        <shortName evidence="57">VSDL</shortName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="46">Pro atrial natriuretic factor 31-67</fullName>
        <shortName evidence="46">proANF 31-67</shortName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="59">Pro atrial natriuretic peptide 31-67</fullName>
        <shortName evidence="59">proANP 31-67</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="57">Kaliuretic peptide</fullName>
        <shortName evidence="57">KP</shortName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="55">Pro atrial natriuretic factor 79-98</fullName>
        <shortName evidence="55">proANF 79-98</shortName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="59">Pro atrial natriuretic peptide 79-98</fullName>
        <shortName evidence="59">proANP 79-98</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="49">Urodilatin</fullName>
        <shortName evidence="58">URO</shortName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="49">CDD 95-126</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="56">CDD-ANP (95-126)</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="48">Pro atrial natriuretic peptide 95-126</fullName>
        <shortName evidence="48">proANP 95-126</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="59">Auriculin-C</fullName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="1">Atrial natriuretic factor 1-33</fullName>
        <shortName evidence="1">ANF 1-33</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="59">Auriculin-D</fullName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="1">Atrial natriuretic factor 3-33</fullName>
        <shortName evidence="1">ANF 3-33</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="52">Atrial natriuretic peptide</fullName>
        <shortName evidence="52">ANP</shortName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="51">Alpha-atrial natriuretic peptide</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="51">Alpha-hANP</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="46">Atrial natriuretic factor</fullName>
        <shortName evidence="46">ANF</shortName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="52">CDD-ANF</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="58">CDD-ANP (99-126)</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="1">Cardionatrin</fullName>
      </alternativeName>
      <alternativeName>
        <fullName evidence="46">Pro atrial natriuretic factor 99-126</fullName>
        <shortName evidence="46">proANF 99-126</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="59">Auriculin-B</fullName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="1">Atrial natriuretic factor 8-33</fullName>
        <shortName evidence="1">ANF 8-33</shortName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="1">Auriculin-A</fullName>
      </recommendedName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="1">Atriopeptin-1</fullName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="1">Atriopeptin I</fullName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="1">Atriopeptin-2</fullName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="1">Atriopeptin II</fullName>
      </alternativeName>
    </component>
    <component>
      <recommendedName>
        <fullName evidence="1">Atriopeptin-3</fullName>
      </recommendedName>
      <alternativeName>
        <fullName evidence="1">Atriopeptin III</fullName>
      </alternativeName>
    </component>
  </protein>
  <gene>
    <name type="primary">NPPA</name>
    <name type="synonym">ANP</name>
    <name type="synonym">PND</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1984" name="Nature" volume="309" first="724" last="726">
      <title>Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide.</title>
      <authorList>
        <person name="Oikawa S."/>
        <person name="Imai M."/>
        <person name="Ueno A."/>
        <person name="Tanaka S."/>
        <person name="Noguchi T."/>
        <person name="Nakazato H."/>
        <person name="Kangawa K."/>
        <person name="Fukuda A."/>
        <person name="Matsuo H."/>
      </authorList>
      <dbReference type="PubMed" id="6203042"/>
      <dbReference type="DOI" id="10.1038/309724a0"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1984" name="Nature" volume="310" first="699" last="701">
      <title>mRNA sequence for human cardiodilatin-atrial natriuretic factor precursor and regulation of precursor mRNA in rat atria.</title>
      <authorList>
        <person name="Nakayama K."/>
        <person name="Ohkubo H."/>
        <person name="Hirose T."/>
        <person name="Inayama S."/>
        <person name="Nakanishi S."/>
      </authorList>
      <dbReference type="PubMed" id="6547996"/>
      <dbReference type="DOI" id="10.1038/310699a0"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1984" name="Nature" volume="312" first="654" last="656">
      <title>Gene structure of human cardiac hormone precursor, pronatriodilatin.</title>
      <authorList>
        <person name="Nemer M."/>
        <person name="Chamberland M."/>
        <person name="Sirois D."/>
        <person name="Argentin S."/>
        <person name="Drouin J."/>
        <person name="Dixon R.A.F."/>
        <person name="Zivin R.A."/>
        <person name="Condra J.H."/>
      </authorList>
      <dbReference type="PubMed" id="6095118"/>
      <dbReference type="DOI" id="10.1038/312654a0"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="1984" name="Nature" volume="312" first="656" last="658">
      <title>Nucleotide sequence of the gene encoding human atrial natriuretic factor precursor.</title>
      <authorList>
        <person name="Greenberg B.D."/>
        <person name="Bencen G.H."/>
        <person name="Seilhamer J.J."/>
        <person name="Lewicki J.A."/>
        <person name="Fiddes J.C."/>
      </authorList>
      <dbReference type="PubMed" id="6095119"/>
      <dbReference type="DOI" id="10.1038/312656a0"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="1984" name="Science" volume="226" first="1206" last="1209">
      <title>Nucleotide sequences of the human and mouse atrial natriuretic factor genes.</title>
      <authorList>
        <person name="Seidman C.E."/>
        <person name="Bloch K.D."/>
        <person name="Klein K.A."/>
        <person name="Smith J.A."/>
        <person name="Seidman J.G."/>
      </authorList>
      <dbReference type="PubMed" id="6542248"/>
      <dbReference type="DOI" id="10.1126/science.6542248"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1985" name="Hypertension" volume="7" first="I31" last="I34">
      <title>Molecular studies of the atrial natriuretic factor gene.</title>
      <authorList>
        <person name="Seidman C.E."/>
        <person name="Bloch K.D."/>
        <person name="Zisfein J."/>
        <person name="Smit J."/>
        <person name="Haber E."/>
        <person name="Homcy C."/>
        <person name="Duby A.D."/>
        <person name="Choi E."/>
        <person name="Graham R.M."/>
        <person name="Seidman J.G."/>
      </authorList>
      <dbReference type="PubMed" id="3158606"/>
      <dbReference type="DOI" id="10.1161/01.hyp.7.3_pt_2.i31"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="7">
    <citation type="submission" date="2007-12" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
      <title>The DNA sequence and biological annotation of human chromosome 1.</title>
      <authorList>
        <person name="Gregory S.G."/>
        <person name="Barlow K.F."/>
        <person name="McLay K.E."/>
        <person name="Kaul R."/>
        <person name="Swarbreck D."/>
        <person name="Dunham A."/>
        <person name="Scott C.E."/>
        <person name="Howe K.L."/>
        <person name="Woodfine K."/>
        <person name="Spencer C.C.A."/>
        <person name="Jones M.C."/>
        <person name="Gillson C."/>
        <person name="Searle S."/>
        <person name="Zhou Y."/>
        <person name="Kokocinski F."/>
        <person name="McDonald L."/>
        <person name="Evans R."/>
        <person name="Phillips K."/>
        <person name="Atkinson A."/>
        <person name="Cooper R."/>
        <person name="Jones C."/>
        <person name="Hall R.E."/>
        <person name="Andrews T.D."/>
        <person name="Lloyd C."/>
        <person name="Ainscough R."/>
        <person name="Almeida J.P."/>
        <person name="Ambrose K.D."/>
        <person name="Anderson F."/>
        <person name="Andrew R.W."/>
        <person name="Ashwell R.I.S."/>
        <person name="Aubin K."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C.L."/>
        <person name="Bailey J."/>
        <person name="Beasley H."/>
        <person name="Bethel G."/>
        <person name="Bird C.P."/>
        <person name="Bray-Allen S."/>
        <person name="Brown J.Y."/>
        <person name="Brown A.J."/>
        <person name="Buckley D."/>
        <person name="Burton J."/>
        <person name="Bye J."/>
        <person name="Carder C."/>
        <person name="Chapman J.C."/>
        <person name="Clark S.Y."/>
        <person name="Clarke G."/>
        <person name="Clee C."/>
        <person name="Cobley V."/>
        <person name="Collier R.E."/>
        <person name="Corby N."/>
        <person name="Coville G.J."/>
        <person name="Davies J."/>
        <person name="Deadman R."/>
        <person name="Dunn M."/>
        <person name="Earthrowl M."/>
        <person name="Ellington A.G."/>
        <person name="Errington H."/>
        <person name="Frankish A."/>
        <person name="Frankland J."/>
        <person name="French L."/>
        <person name="Garner P."/>
        <person name="Garnett J."/>
        <person name="Gay L."/>
        <person name="Ghori M.R.J."/>
        <person name="Gibson R."/>
        <person name="Gilby L.M."/>
        <person name="Gillett W."/>
        <person name="Glithero R.J."/>
        <person name="Grafham D.V."/>
        <person name="Griffiths C."/>
        <person name="Griffiths-Jones S."/>
        <person name="Grocock R."/>
        <person name="Hammond S."/>
        <person name="Harrison E.S.I."/>
        <person name="Hart E."/>
        <person name="Haugen E."/>
        <person name="Heath P.D."/>
        <person name="Holmes S."/>
        <person name="Holt K."/>
        <person name="Howden P.J."/>
        <person name="Hunt A.R."/>
        <person name="Hunt S.E."/>
        <person name="Hunter G."/>
        <person name="Isherwood J."/>
        <person name="James R."/>
        <person name="Johnson C."/>
        <person name="Johnson D."/>
        <person name="Joy A."/>
        <person name="Kay M."/>
        <person name="Kershaw J.K."/>
        <person name="Kibukawa M."/>
        <person name="Kimberley A.M."/>
        <person name="King A."/>
        <person name="Knights A.J."/>
        <person name="Lad H."/>
        <person name="Laird G."/>
        <person name="Lawlor S."/>
        <person name="Leongamornlert D.A."/>
        <person name="Lloyd D.M."/>
        <person name="Loveland J."/>
        <person name="Lovell J."/>
        <person name="Lush M.J."/>
        <person name="Lyne R."/>
        <person name="Martin S."/>
        <person name="Mashreghi-Mohammadi M."/>
        <person name="Matthews L."/>
        <person name="Matthews N.S.W."/>
        <person name="McLaren S."/>
        <person name="Milne S."/>
        <person name="Mistry S."/>
        <person name="Moore M.J.F."/>
        <person name="Nickerson T."/>
        <person name="O'Dell C.N."/>
        <person name="Oliver K."/>
        <person name="Palmeiri A."/>
        <person name="Palmer S.A."/>
        <person name="Parker A."/>
        <person name="Patel D."/>
        <person name="Pearce A.V."/>
        <person name="Peck A.I."/>
        <person name="Pelan S."/>
        <person name="Phelps K."/>
        <person name="Phillimore B.J."/>
        <person name="Plumb R."/>
        <person name="Rajan J."/>
        <person name="Raymond C."/>
        <person name="Rouse G."/>
        <person name="Saenphimmachak C."/>
        <person name="Sehra H.K."/>
        <person name="Sheridan E."/>
        <person name="Shownkeen R."/>
        <person name="Sims S."/>
        <person name="Skuce C.D."/>
        <person name="Smith M."/>
        <person name="Steward C."/>
        <person name="Subramanian S."/>
        <person name="Sycamore N."/>
        <person name="Tracey A."/>
        <person name="Tromans A."/>
        <person name="Van Helmond Z."/>
        <person name="Wall M."/>
        <person name="Wallis J.M."/>
        <person name="White S."/>
        <person name="Whitehead S.L."/>
        <person name="Wilkinson J.E."/>
        <person name="Willey D.L."/>
        <person name="Williams H."/>
        <person name="Wilming L."/>
        <person name="Wray P.W."/>
        <person name="Wu Z."/>
        <person name="Coulson A."/>
        <person name="Vaudin M."/>
        <person name="Sulston J.E."/>
        <person name="Durbin R.M."/>
        <person name="Hubbard T."/>
        <person name="Wooster R."/>
        <person name="Dunham I."/>
        <person name="Carter N.P."/>
        <person name="McVean G."/>
        <person name="Ross M.T."/>
        <person name="Harrow J."/>
        <person name="Olson M.V."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Bentley D.R."/>
      </authorList>
      <dbReference type="PubMed" id="16710414"/>
      <dbReference type="DOI" id="10.1038/nature04727"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <source>
      <tissue>Prostate</tissue>
    </source>
  </reference>
  <reference key="10">
    <citation type="journal article" date="1984" name="Biochem. Biophys. Res. Commun." volume="125" first="797" last="802">
      <title>Cloning of genomic DNA for human atrial natriuretic factor.</title>
      <authorList>
        <person name="Maki M."/>
        <person name="Parmentier M."/>
        <person name="Inagami T."/>
      </authorList>
      <dbReference type="PubMed" id="6097248"/>
      <dbReference type="DOI" id="10.1016/0006-291x(84)90609-0"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-75</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="1984" name="Proc. Natl. Acad. Sci. U.S.A." volume="81" first="6325" last="6329">
      <title>Molecular cloning and characterization of DNA sequences encoding rat and human atrial natriuretic factors.</title>
      <authorList>
        <person name="Zivin R.A."/>
        <person name="Condra J.H."/>
        <person name="Dixon R.A.F."/>
        <person name="Seidah N.G."/>
        <person name="Chretien M."/>
        <person name="Nemer M."/>
        <person name="Chamberland M."/>
        <person name="Drouin J."/>
      </authorList>
      <dbReference type="PubMed" id="6238331"/>
      <dbReference type="DOI" id="10.1073/pnas.81.20.6325"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] OF 118-151</scope>
    <scope>VARIANT ARG-ARG-151 EXT</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="1984" name="Biochem. Biophys. Res. Commun." volume="118" first="131" last="139">
      <title>Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP).</title>
      <authorList>
        <person name="Kangawa K."/>
        <person name="Matsuo H."/>
      </authorList>
      <dbReference type="PubMed" id="6230082"/>
      <dbReference type="DOI" id="10.1016/0006-291x(84)91077-5"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 124-151</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="1985" name="Nature" volume="313" first="397" last="400">
      <title>Structural identification of beta- and gamma-human atrial natriuretic polypeptides.</title>
      <authorList>
        <person name="Kangawa K."/>
        <person name="Fukuda A."/>
        <person name="Matsuo H."/>
      </authorList>
      <dbReference type="PubMed" id="3838202"/>
      <dbReference type="DOI" id="10.1038/313397a0"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 26-151</scope>
    <scope>SUBUNIT (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>DISULFIDE BOND</scope>
    <source>
      <tissue evidence="51">Heart atrium</tissue>
    </source>
  </reference>
  <reference key="14">
    <citation type="journal article" date="1988" name="J. Mol. Med." volume="66" first="752" last="759">
      <title>Isolation and structural analysis of 'urodilatin', a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine.</title>
      <authorList>
        <person name="Schulz-Knappe P."/>
        <person name="Forssmann K."/>
        <person name="Herbst F."/>
        <person name="Hock D."/>
        <person name="Pipkorn R."/>
        <person name="Forssmann W.G."/>
      </authorList>
      <dbReference type="PubMed" id="2972874"/>
      <dbReference type="DOI" id="10.1007/bf01726570"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 120-151</scope>
    <scope>SYNTHESIS (URODILATIN)</scope>
    <scope>SUBCELLULAR LOCATION (URODILATIN AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>TISSUE SPECIFICITY (URODILATIN)</scope>
    <scope>PROTEOLYTIC PROCESSING (URODILATIN)</scope>
    <source>
      <tissue evidence="49">Urine</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="1991" name="Eur. J. Biochem." volume="196" first="281" last="286">
      <title>Hydrolysis of intact and Cys-Phe-cleaved human atrial natriuretic peptide in vitro by human tissue kallikrein.</title>
      <authorList>
        <person name="Vanneste Y."/>
        <person name="Michel A."/>
        <person name="Deschodt-Lanckman M."/>
      </authorList>
      <dbReference type="PubMed" id="1826098"/>
      <dbReference type="DOI" id="10.1111/j.1432-1033.1991.tb15815.x"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 124-151</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="1987" name="Biochem. Biophys. Res. Commun." volume="148" first="1540" last="1548">
      <title>Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta.</title>
      <authorList>
        <person name="Vesely D.L."/>
        <person name="Norris J.S."/>
        <person name="Walters J.M."/>
        <person name="Jespersen R.R."/>
        <person name="Baeyens D.A."/>
      </authorList>
      <dbReference type="PubMed" id="2825692"/>
      <dbReference type="DOI" id="10.1016/s0006-291x(87)80307-8"/>
    </citation>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="1988" name="Biochem. J." volume="254" first="531" last="537">
      <title>Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site.</title>
      <authorList>
        <person name="Vanneste Y."/>
        <person name="Michel A."/>
        <person name="Dimaline R."/>
        <person name="Najdovski T."/>
        <person name="Deschodt-Lanckman M."/>
      </authorList>
      <dbReference type="PubMed" id="2972276"/>
      <dbReference type="DOI" id="10.1042/bj2540531"/>
    </citation>
    <scope>PROTEOLYTIC PROCESSING BY MME (ATRIAL NATRIURETIC FACTOR)</scope>
    <scope>CLEAVAGE SITE</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="1989" name="Proc. Soc. Exp. Biol. Med." volume="192" first="230" last="235">
      <title>Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans.</title>
      <authorList>
        <person name="Vesely D.L."/>
        <person name="Norsk P."/>
        <person name="Winters C.J."/>
        <person name="Rico D.M."/>
        <person name="Sallman A.L."/>
        <person name="Epstein M."/>
      </authorList>
      <dbReference type="PubMed" id="2532366"/>
      <dbReference type="DOI" id="10.3181/00379727-192-42990"/>
    </citation>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>SUBCELLULAR LOCATION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>PROTEOLYTIC PROCESSING</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="163" first="830" last="835">
      <title>Phosphorylation and dephosphorylation of the natriuretic peptide urodilatin (CDD-/ANP-95-126) and the effect on biological activity.</title>
      <authorList>
        <person name="Doerner T."/>
        <person name="Gagelmann M."/>
        <person name="Feller S."/>
        <person name="Herbst F."/>
        <person name="Forssmann W.G."/>
      </authorList>
      <dbReference type="PubMed" id="2528951"/>
      <dbReference type="DOI" id="10.1016/0006-291x(89)92297-3"/>
    </citation>
    <scope>SYNTHESIS (URODILATIN)</scope>
    <scope>FUNCTION (URODILATIN)</scope>
    <scope>PHOSPHORYLATION AT SER-129 (URODILATIN)</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="1990" name="Peptides" volume="11" first="193" last="197">
      <title>Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126.</title>
      <authorList>
        <person name="Vesely D.L."/>
        <person name="Cornett L.E."/>
        <person name="MacLeod S.L."/>
        <person name="Nash A.A."/>
        <person name="Norris J.S."/>
      </authorList>
      <dbReference type="PubMed" id="2162527"/>
      <dbReference type="DOI" id="10.1016/0196-9781(90)90070-l"/>
    </citation>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="23060" last="23067">
      <title>Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera.</title>
      <authorList>
        <person name="Bennett B.D."/>
        <person name="Bennett G.L."/>
        <person name="Vitangcol R.V."/>
        <person name="Jewett J.R."/>
        <person name="Burnier J."/>
        <person name="Henzel W."/>
        <person name="Lowe D.G."/>
      </authorList>
      <dbReference type="PubMed" id="1660465"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(18)54463-x"/>
    </citation>
    <scope>RECEPTOR-BINDING (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="1991" name="Science" volume="252" first="120" last="123">
      <title>Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).</title>
      <authorList>
        <person name="Koller K.J."/>
        <person name="Lowe D.G."/>
        <person name="Bennett G.L."/>
        <person name="Minamino N."/>
        <person name="Kangawa K."/>
        <person name="Matsuo H."/>
        <person name="Goeddel D.V."/>
      </authorList>
      <dbReference type="PubMed" id="1672777"/>
      <dbReference type="DOI" id="10.1126/science.1672777"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="1993" name="Hypertension" volume="21" first="432" last="438">
      <title>Urodilatin binds to and activates renal receptors for atrial natriuretic peptide.</title>
      <authorList>
        <person name="Valentin J.P."/>
        <person name="Sechi L.A."/>
        <person name="Qui C."/>
        <person name="Schambelan M."/>
        <person name="Humphreys M.H."/>
      </authorList>
      <dbReference type="PubMed" id="8384600"/>
      <dbReference type="DOI" id="10.1161/01.hyp.21.4.432"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE AND URODILATIN)</scope>
    <scope>TISSUE SPECIFICITY (ATRIAL NATRIURETIC PEPTIDE AND URODILATIN)</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="1993" name="Pflugers Arch." volume="423" first="372" last="377">
      <title>Development and application of a urodilatin (CDD/ANP-95-126)-specific radioimmunoassay.</title>
      <authorList>
        <person name="Drummer C."/>
        <person name="Fiedler F."/>
        <person name="Bub A."/>
        <person name="Kleefeld D."/>
        <person name="Dimitriades E."/>
        <person name="Gerzer R."/>
        <person name="Forssmann W.G."/>
      </authorList>
      <dbReference type="PubMed" id="8351194"/>
      <dbReference type="DOI" id="10.1007/bf00374930"/>
    </citation>
    <scope>SYNTHESIS (URODILATIN)</scope>
    <scope>FUNCTION (URODILATIN)</scope>
    <scope>SUBCELLULAR LOCATION (ATRIAL NATRIURETIC PEPTIDE AND URODILATIN)</scope>
    <scope>TISSUE SPECIFICITY (ATRIAL NATRIURETIC PEPTIDE AND URODILATIN)</scope>
    <scope>PROTEOLYTIC PROCESSING (URODILATIN)</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="1994" name="Circulation" volume="90" first="1129" last="1140">
      <title>Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.</title>
      <authorList>
        <person name="Vesely D.L."/>
        <person name="Douglass M.A."/>
        <person name="Dietz J.R."/>
        <person name="Gower W.R. Jr."/>
        <person name="McCormick M.T."/>
        <person name="Rodriguez-Paz G."/>
        <person name="Schocken D.D."/>
      </authorList>
      <dbReference type="PubMed" id="8087923"/>
      <dbReference type="DOI" id="10.1161/01.cir.90.3.1129"/>
    </citation>
    <scope>SYNTHESIS (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="1994" name="Clin. Sci." volume="87" first="311" last="317">
      <title>N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126).</title>
      <authorList>
        <person name="Buckley M.G."/>
        <person name="Markandu N.D."/>
        <person name="Sagnella G.A."/>
        <person name="MacGregor G.A."/>
      </authorList>
      <dbReference type="PubMed" id="7955907"/>
      <dbReference type="DOI" id="10.1042/cs0870311"/>
    </citation>
    <scope>SYNTHESIS (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE AND VESSEL DILATOR)</scope>
    <scope>SUBCELLULAR LOCATION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>PROTEOLYTIC PROCESSING</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="1994" name="Peptides" volume="15" first="861" last="867">
      <title>Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites.</title>
      <authorList>
        <person name="Gower W.R. Jr."/>
        <person name="Chiou S."/>
        <person name="Skolnick K.A."/>
        <person name="Vesely D.L."/>
      </authorList>
      <dbReference type="PubMed" id="7984506"/>
      <dbReference type="DOI" id="10.1016/0196-9781(94)90043-4"/>
    </citation>
    <scope>SYNTHESIS (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>SUBCELLULAR LOCATION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>TISSUE SPECIFICITY (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>PROTEOLYTIC PROCESSING</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="1994" name="Regul. Pept." volume="53" first="111" last="122">
      <title>Lack of biologic activity or specific binding of amino-terminal pro-ANP segments in the rat.</title>
      <authorList>
        <person name="Weir M.L."/>
        <person name="Honrath U."/>
        <person name="Flynn T.G."/>
        <person name="Sonnenberg H."/>
      </authorList>
      <dbReference type="PubMed" id="7831500"/>
      <dbReference type="DOI" id="10.1016/0167-0115(94)90612-2"/>
    </citation>
    <scope>FUNCTION (VESSEL DILATOR)</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="1995" name="Chronobiol. Int." volume="12" first="106" last="120">
      <title>Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure.</title>
      <authorList>
        <person name="Sothern R.B."/>
        <person name="Vesely D.L."/>
        <person name="Kanabrocki E.L."/>
        <person name="Hermida R.C."/>
        <person name="Bremner F.W."/>
        <person name="Third J.L."/>
        <person name="Boles M.A."/>
        <person name="Nemchausky B.M."/>
        <person name="Olwin J.H."/>
        <person name="Scheving L.E."/>
      </authorList>
      <dbReference type="PubMed" id="8653797"/>
      <dbReference type="DOI" id="10.3109/07420529509064506"/>
    </citation>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>SUBCELLULAR LOCATION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="1995" name="Endocrinology" volume="136" first="2033" last="2039">
      <title>Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.</title>
      <authorList>
        <person name="Chiou S."/>
        <person name="Vesely D.L."/>
      </authorList>
      <dbReference type="PubMed" id="7720651"/>
      <dbReference type="DOI" id="10.1210/endo.136.5.7720651"/>
    </citation>
    <scope>SYNTHESIS (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="1995" name="J. Endocrinol." volume="146" first="373" last="380">
      <title>Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion.</title>
      <authorList>
        <person name="Vesely D.L."/>
        <person name="Chiou S."/>
        <person name="Douglass M.A."/>
        <person name="McCormick M.T."/>
        <person name="Rodriguez-Paz G."/>
        <person name="Schocken D.D."/>
      </authorList>
      <dbReference type="PubMed" id="7595132"/>
      <dbReference type="DOI" id="10.1677/joe.0.1460373"/>
    </citation>
    <scope>SYNTHESIS (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR; KALIURETIC PEPTIDE AND ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="1996" name="Am. J. Physiol." volume="270" first="F301" last="F310">
      <title>Postprandial natriuresis in humans: further evidence that urodilatin, not ANP, modulates sodium excretion.</title>
      <authorList>
        <person name="Drummer C."/>
        <person name="Franck W."/>
        <person name="Heer M."/>
        <person name="Forssmann W.G."/>
        <person name="Gerzer R."/>
        <person name="Goetz K."/>
      </authorList>
      <dbReference type="PubMed" id="8779891"/>
      <dbReference type="DOI" id="10.1152/ajprenal.1996.270.2.f301"/>
    </citation>
    <scope>FUNCTION (URODILATIN)</scope>
    <scope>SUBCELLULAR LOCATION (ATRIAL NATRIURETIC PEPTIDE AND URODILATIN)</scope>
    <scope>TISSUE SPECIFICITY (URODILATIN)</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="1996" name="Am. J. Physiol." volume="271" first="F489" last="F497">
      <title>Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects.</title>
      <authorList>
        <person name="Meyer M."/>
        <person name="Richter R."/>
        <person name="Brunkhorst R."/>
        <person name="Wrenger E."/>
        <person name="Schulz-Knappe P."/>
        <person name="Kist A."/>
        <person name="Mentz P."/>
        <person name="Brabant E.G."/>
        <person name="Koch K.M."/>
        <person name="Rechkemmer G."/>
        <person name="Forssmann W.G."/>
      </authorList>
      <dbReference type="PubMed" id="8853410"/>
      <dbReference type="DOI" id="10.1152/ajprenal.1996.271.3.f489"/>
    </citation>
    <scope>FUNCTION (URODILATIN)</scope>
    <scope>SUBCELLULAR LOCATION (URODILATIN)</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="1998" name="Nephrol. Dial. Transplant." volume="13" first="2529" last="2535">
      <title>The renal natriuretic peptide urodilatin is present in human kidney.</title>
      <authorList>
        <person name="Herten M."/>
        <person name="Lenz W."/>
        <person name="Gerzer R."/>
        <person name="Drummer C."/>
      </authorList>
      <dbReference type="PubMed" id="9794555"/>
      <dbReference type="DOI" id="10.1093/ndt/13.10.2529"/>
    </citation>
    <scope>SUBCELLULAR LOCATION (URODILATIN)</scope>
    <scope>TISSUE SPECIFICITY (ATRIAL NATRIURETIC PEPTIDE AND URODILATIN)</scope>
    <scope>PROTEOLYTIC PROCESSING (URODILATIN)</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="1999" name="Kidney Int." volume="55" first="91" last="99">
      <title>Regulation of natriuretic peptide (urodilatin) release in a human kidney cell line.</title>
      <authorList>
        <person name="Lenz W."/>
        <person name="Herten M."/>
        <person name="Gerzer R."/>
        <person name="Drummer C."/>
      </authorList>
      <dbReference type="PubMed" id="9893117"/>
      <dbReference type="DOI" id="10.1046/j.1523-1755.1999.00242.x"/>
    </citation>
    <scope>FUNCTION (URODILATIN AND ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>SUBCELLULAR LOCATION (URODILATIN AND ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2000" name="Metabolism" volume="49" first="1592" last="1597">
      <title>Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.</title>
      <authorList>
        <person name="Vesely D.L."/>
        <person name="Perez-Lamboy G.I."/>
        <person name="Schocken D.D."/>
      </authorList>
      <dbReference type="PubMed" id="11145122"/>
      <dbReference type="DOI" id="10.1053/meta.2000.18557"/>
    </citation>
    <scope>FUNCTION (LONG-ACTING NATRIURETIC PEPTIDE; VESSEL DILATOR AND KALIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="8525" last="8529">
      <title>Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.</title>
      <authorList>
        <person name="Yan W."/>
        <person name="Wu F."/>
        <person name="Morser J."/>
        <person name="Wu Q."/>
      </authorList>
      <dbReference type="PubMed" id="10880574"/>
      <dbReference type="DOI" id="10.1073/pnas.150149097"/>
    </citation>
    <scope>PROTEOLYTIC PROCESSING</scope>
    <scope>CLEAVAGE SITE</scope>
    <scope>MUTAGENESIS OF ARG-123</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="52363" last="52370">
      <title>Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin.</title>
      <authorList>
        <person name="Knappe S."/>
        <person name="Wu F."/>
        <person name="Masikat M.R."/>
        <person name="Morser J."/>
        <person name="Wu Q."/>
      </authorList>
      <dbReference type="PubMed" id="14559895"/>
      <dbReference type="DOI" id="10.1074/jbc.m309991200"/>
    </citation>
    <scope>PROTEOLYTIC PROCESSING</scope>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="3622" last="3628">
      <title>Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.</title>
      <authorList>
        <person name="Birkenfeld A.L."/>
        <person name="Boschmann M."/>
        <person name="Moro C."/>
        <person name="Adams F."/>
        <person name="Heusser K."/>
        <person name="Franke G."/>
        <person name="Berlan M."/>
        <person name="Luft F.C."/>
        <person name="Lafontan M."/>
        <person name="Jordan J."/>
      </authorList>
      <dbReference type="PubMed" id="15741263"/>
      <dbReference type="DOI" id="10.1210/jc.2004-1953"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>SUBCELLULAR LOCATION (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="40">
    <citation type="journal article" date="2006" name="Clin. Chem." volume="52" first="82" last="87">
      <title>Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form.</title>
      <authorList>
        <person name="Brandt I."/>
        <person name="Lambeir A.M."/>
        <person name="Ketelslegers J.M."/>
        <person name="Vanderheyden M."/>
        <person name="Scharpe S."/>
        <person name="De Meester I."/>
      </authorList>
      <dbReference type="PubMed" id="16254193"/>
      <dbReference type="DOI" id="10.1373/clinchem.2005.057638"/>
    </citation>
    <scope>PROTEOLYTIC PROCESSING BY MME (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="41">
    <citation type="journal article" date="2006" name="J. Am. Coll. Cardiol." volume="48" first="499" last="505">
      <title>Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.</title>
      <authorList>
        <person name="Rubattu S."/>
        <person name="Bigatti G."/>
        <person name="Evangelista A."/>
        <person name="Lanzani C."/>
        <person name="Stanzione R."/>
        <person name="Zagato L."/>
        <person name="Manunta P."/>
        <person name="Marchitti S."/>
        <person name="Venturelli V."/>
        <person name="Bianchi G."/>
        <person name="Volpe M."/>
        <person name="Stella P."/>
      </authorList>
      <dbReference type="PubMed" id="16875975"/>
      <dbReference type="DOI" id="10.1016/j.jacc.2005.12.081"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>VARIANT ARG-ARG-151 EXT</scope>
  </reference>
  <reference key="42">
    <citation type="journal article" date="2008" name="Diabetes" volume="57" first="3199" last="3204">
      <title>Atrial natriuretic peptide induces postprandial lipid oxidation in humans.</title>
      <authorList>
        <person name="Birkenfeld A.L."/>
        <person name="Budziarek P."/>
        <person name="Boschmann M."/>
        <person name="Moro C."/>
        <person name="Adams F."/>
        <person name="Franke G."/>
        <person name="Berlan M."/>
        <person name="Marques M.A."/>
        <person name="Sweep F.C."/>
        <person name="Luft F.C."/>
        <person name="Lafontan M."/>
        <person name="Jordan J."/>
      </authorList>
      <dbReference type="PubMed" id="18835931"/>
      <dbReference type="DOI" id="10.2337/db08-0649"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>SUBCELLULAR LOCATION (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="43">
    <citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="410" first="398" last="403">
      <title>Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK.</title>
      <authorList>
        <person name="Souza S.C."/>
        <person name="Chau M.D."/>
        <person name="Yang Q."/>
        <person name="Gauthier M.S."/>
        <person name="Clairmont K.B."/>
        <person name="Wu Z."/>
        <person name="Gromada J."/>
        <person name="Dole W.P."/>
      </authorList>
      <dbReference type="PubMed" id="21672517"/>
      <dbReference type="DOI" id="10.1016/j.bbrc.2011.05.143"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>TISSUE SPECIFICITY (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="44">
    <citation type="journal article" date="2012" name="Clin. Chem." volume="58" first="757" last="767">
      <title>First identification of circulating prepro-A-type natriuretic peptide (preproANP) signal peptide fragments in humans: initial assessment as cardiovascular biomarkers.</title>
      <authorList>
        <person name="Pemberton C.J."/>
        <person name="Siriwardena M."/>
        <person name="Kleffmann T."/>
        <person name="Ruygrok P."/>
        <person name="Palmer S.C."/>
        <person name="Yandle T.G."/>
        <person name="Richards A.M."/>
      </authorList>
      <dbReference type="PubMed" id="22291141"/>
      <dbReference type="DOI" id="10.1373/clinchem.2011.176990"/>
    </citation>
    <scope>TISSUE SPECIFICITY (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="45">
    <citation type="journal article" date="2012" name="J. Clin. Invest." volume="122" first="1022" last="1036">
      <title>Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.</title>
      <authorList>
        <person name="Bordicchia M."/>
        <person name="Liu D."/>
        <person name="Amri E.Z."/>
        <person name="Ailhaud G."/>
        <person name="Dessi-Fulgheri P."/>
        <person name="Zhang C."/>
        <person name="Takahashi N."/>
        <person name="Sarzani R."/>
        <person name="Collins S."/>
      </authorList>
      <dbReference type="PubMed" id="22307324"/>
      <dbReference type="DOI" id="10.1172/jci59701"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="46">
    <citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E113108" last="E113108">
      <title>The C2238/alphaANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.</title>
      <authorList>
        <person name="Rubattu S."/>
        <person name="Marchitti S."/>
        <person name="Bianchi F."/>
        <person name="Di Castro S."/>
        <person name="Stanzione R."/>
        <person name="Cotugno M."/>
        <person name="Bozzao C."/>
        <person name="Sciarretta S."/>
        <person name="Volpe M."/>
      </authorList>
      <dbReference type="PubMed" id="25401746"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0113108"/>
    </citation>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="47">
    <citation type="journal article" date="2018" name="Front. Neurosci." volume="12" first="864" last="864">
      <title>Natriuretic Peptides in Post-mortem Brain Tissue and Cerebrospinal Fluid of Non-demented Humans and Alzheimer's Disease Patients.</title>
      <authorList>
        <person name="Mahinrad S."/>
        <person name="Bulk M."/>
        <person name="van der Velpen I."/>
        <person name="Mahfouz A."/>
        <person name="van Roon-Mom W."/>
        <person name="Fedarko N."/>
        <person name="Yasar S."/>
        <person name="Sabayan B."/>
        <person name="van Heemst D."/>
        <person name="van der Weerd L."/>
      </authorList>
      <dbReference type="PubMed" id="30534047"/>
      <dbReference type="DOI" id="10.3389/fnins.2018.00864"/>
    </citation>
    <scope>SUBCELLULAR LOCATION (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>TISSUE SPECIFICITY (ATRIAL NATRIURETIC PEPTIDE)</scope>
  </reference>
  <reference key="48">
    <citation type="journal article" date="1994" name="Biochemistry" volume="33" first="8897" last="8904">
      <title>Solution conformation of an atrial natriuretic peptide variant selective for the type A receptor.</title>
      <authorList>
        <person name="Fairbrother W.J."/>
        <person name="McDowell R.S."/>
        <person name="Cunningham B.C."/>
      </authorList>
      <dbReference type="PubMed" id="8043577"/>
      <dbReference type="DOI" id="10.1021/bi00196a006"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 124-151 MUTANT SELECTIVE FOR NPR-C RECEPTOR</scope>
  </reference>
  <reference key="49">
    <citation type="journal article" date="2006" name="J. Mol. Biol." volume="361" first="698" last="714">
      <title>Structural determinants of natriuretic peptide receptor specificity and degeneracy.</title>
      <authorList>
        <person name="He X.-L."/>
        <person name="Dukkipati A."/>
        <person name="Garcia K.C."/>
      </authorList>
      <dbReference type="PubMed" id="16870210"/>
      <dbReference type="DOI" id="10.1016/j.jmb.2006.06.060"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 129-149 IN COMPLEX WITH NPR3</scope>
    <scope>DISULFIDE BOND</scope>
  </reference>
  <reference evidence="64" key="50">
    <citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="4670" last="4679">
      <title>Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.</title>
      <authorList>
        <person name="Ralat L.A."/>
        <person name="Guo Q."/>
        <person name="Ren M."/>
        <person name="Funke T."/>
        <person name="Dickey D.M."/>
        <person name="Potter L.R."/>
        <person name="Tang W.J."/>
      </authorList>
      <dbReference type="PubMed" id="21098034"/>
      <dbReference type="DOI" id="10.1074/jbc.m110.173252"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.03 ANGSTROMS) OF 124-151</scope>
    <scope>FUNCTION (ATRIAL NATRIURETIC PEPTIDE)</scope>
    <scope>PROTEOLYTIC DEGRADATION BY IDE (ATRIAL NATRIURETIC PEPTIDE AND URODILATIN)</scope>
    <scope>REGION</scope>
    <scope>MUTAGENESIS OF 124-SER--ARG-126; 124-SER--SER-129 AND 147-ASN--TYR-151</scope>
  </reference>
  <reference key="51">
    <citation type="journal article" date="2008" name="N. Engl. J. Med." volume="359" first="158" last="165">
      <title>Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.</title>
      <authorList>
        <person name="Hodgson-Zingman D.M."/>
        <person name="Karst M.L."/>
        <person name="Zingman L.V."/>
        <person name="Heublein D.M."/>
        <person name="Darbar D."/>
        <person name="Herron K.J."/>
        <person name="Ballew J.D."/>
        <person name="de Andrade M."/>
        <person name="Burnett J.C. Jr."/>
        <person name="Olson T.M."/>
      </authorList>
      <dbReference type="PubMed" id="18614783"/>
      <dbReference type="DOI" id="10.1056/nejmoa0706300"/>
    </citation>
    <scope>INVOLVEMENT IN ATFB6</scope>
  </reference>
  <reference key="52">
    <citation type="journal article" date="2013" name="Circ. Cardiovasc. Genet." volume="6" first="27" last="36">
      <title>Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of natriuretic peptide precursor A.</title>
      <authorList>
        <person name="Disertori M."/>
        <person name="Quintarelli S."/>
        <person name="Grasso M."/>
        <person name="Pilotto A."/>
        <person name="Narula N."/>
        <person name="Favalli V."/>
        <person name="Canclini C."/>
        <person name="Diegoli M."/>
        <person name="Mazzola S."/>
        <person name="Marini M."/>
        <person name="Del Greco M."/>
        <person name="Bonmassari R."/>
        <person name="Mase M."/>
        <person name="Ravelli F."/>
        <person name="Specchia C."/>
        <person name="Arbustini E."/>
      </authorList>
      <dbReference type="PubMed" id="23275345"/>
      <dbReference type="DOI" id="10.1161/circgenetics.112.963520"/>
    </citation>
    <scope>INVOLVEMENT IN ATRST2</scope>
    <scope>VARIANT ATRST2 GLN-150</scope>
  </reference>
  <comment type="function">
    <molecule>Atrial natriuretic peptide</molecule>
    <text evidence="2 8 10 11 13 16 17 18 19 21 24 25 26 33 34 38 40 41 45">Hormone that plays a key role in mediating cardio-renal homeostasis, and is involved in vascular remodeling and regulating energy metabolism (PubMed:8653797, PubMed:7595132, PubMed:2825692, PubMed:7720651, PubMed:8087923, PubMed:2532366, PubMed:22307324, PubMed:18835931, PubMed:21672517, PubMed:15741263, PubMed:16875975). Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins, such as PRKG1, that drive various biological responses (PubMed:25401746, PubMed:9893117, PubMed:1672777, PubMed:1660465, PubMed:2162527, PubMed:2825692, PubMed:7720651, PubMed:22307324, PubMed:8384600, PubMed:21098034). Regulates vasodilation, natriuresis, diuresis and aldosterone synthesis and is therefore essential for regulating blood pressure, controlling the extracellular fluid volume and maintaining the fluid-electrolyte balance (PubMed:8653797, PubMed:7595132, PubMed:2825692, PubMed:7720651, PubMed:2532366, PubMed:8087923). Also involved in inhibiting cardiac remodeling and cardiac hypertrophy by inducing cardiomyocyte apoptosis and attenuating the growth of cardiomyocytes and fibroblasts (PubMed:16875975). Plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus, and thus prevents pregnancy-induced hypertension (By similarity). In adipose tissue, acts in various cGMP- and PKG-dependent pathways to regulate lipid metabolism and energy homeostasis (PubMed:22307324, PubMed:18835931, PubMed:21672517, PubMed:15741263). This includes up-regulating lipid metabolism and mitochondrial oxygen utilization by activating the AMP-activated protein kinase (AMPK), and increasing energy expenditure by acting via MAPK11 to promote the UCP1-dependent thermogenesis of brown adipose tissue (PubMed:22307324, PubMed:18835931, PubMed:21672517, PubMed:15741263). Binds the clearance receptor NPR3 which removes the hormone from circulation (PubMed:1672777).</text>
  </comment>
  <comment type="function">
    <molecule>Long-acting natriuretic peptide</molecule>
    <text evidence="1 6 18 24 26 33 34 36 38 41">May have a role in cardio-renal homeostasis through regulation of natriuresis, diuresis, vasodilation, and inhibiting aldosterone synthesis (PubMed:8653797, PubMed:7955907, PubMed:8087923, PubMed:2825692, PubMed:7595132, PubMed:2532366). In vitro, promotes the production of cGMP and induces vasodilation (PubMed:2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed:7720651). However reports on the involvement of this peptide in mammal blood volume and blood pressure homeostasis are conflicting; according to a report, in vivo it is not sufficient to activate cGMP and does not inhibit collecting duct transport nor effect diuresis and natriuresis (By similarity). Appears to bind to specific receptors that are distinct from the receptors bound by atrial natriuretic peptide and vessel dilator (PubMed:2162527, PubMed:2825692). Possibly enhances protein excretion in urine by decreasing proximal tubular protein reabsorption (PubMed:11145122).</text>
  </comment>
  <comment type="function">
    <molecule>Vessel dilator</molecule>
    <text evidence="6 18 24 26 33 34 35 36 38 41">May have a role in cardio-renal homeostasis through regulation of natriuresis, diuresis, and vasodilation (PubMed:8653797, PubMed:7955907, PubMed:8087923, PubMed:2532366, PubMed:7595132). In vitro, promotes the production of cGMP and induces vasodilation (PubMed:2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed:7720651, PubMed:7595132). However reports on the involvement of this peptide in mammal blood volume and blood pressure homeostasis are conflicting; according to a report it is not sufficient to activate cGMP and does not inhibit collecting duct transport nor effect diuresis and natriuresis (PubMed:7831500). Appears to bind to specific receptors that are distinct from the receptors bound by the atrial natriuretic and long-acting natriuretic peptides (PubMed:2162527, PubMed:2825692). Possibly functions in protein excretion in urine by maintaining the integrity of the proximal tubules and enhancing protein excretion by decreasing proximal tubular protein reabsorption (PubMed:11145122).</text>
  </comment>
  <comment type="function">
    <molecule>Kaliuretic peptide</molecule>
    <text evidence="6 26 33 34 38">May have a role in cardio-renal homeostasis through regulation of diuresis and inhibiting aldosterone synthesis (PubMed:8087923, PubMed:2825692, PubMed:7595132). In vitro, promotes the production of cGMP and induces vasodilation (PubMed:2825692). May promote natriuresis, at least in part, by enhancing prostaglandin E2 synthesis resulting in the inhibition of renal Na+-K+-ATPase (PubMed:7720651, PubMed:7595132). May have a role in potassium excretion but not sodium excretion (natriuresis) (PubMed:8087923). Possibly enhances protein excretion in urine by decreasing proximal tubular protein reabsorption (PubMed:11145122).</text>
  </comment>
  <comment type="function">
    <molecule>Urodilatin</molecule>
    <text evidence="23 39 40 42 43 45">Hormone produced in the kidneys that appears to be important for maintaining cardio-renal homeostasis (PubMed:8351194, PubMed:8853410, PubMed:8779891). Mediates vasodilation, natriuresis and diuresis primarily in the renal system, in order to maintain the extracellular fluid volume and control the fluid-electrolyte balance (PubMed:2528951, PubMed:8351194, PubMed:8853410, PubMed:8779891). Specifically binds and stimulates cGMP production by renal transmembrane receptors, likely NPR1 (PubMed:8384600, PubMed:9893117). Urodilatin not ANP, may be the natriuretic peptide responsible for the regulation of sodium and water homeostasis in the kidney (PubMed:8779891, PubMed:8384600).</text>
  </comment>
  <comment type="function">
    <molecule>Auriculin-D</molecule>
    <text evidence="1">May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis and in vitro, vasodilates renal artery strips.</text>
  </comment>
  <comment type="function">
    <molecule>Auriculin-B</molecule>
    <text evidence="1">May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis and in vitro, vasodilates renal artery strips.</text>
  </comment>
  <comment type="function">
    <molecule>Auriculin-A</molecule>
    <text evidence="1">May have a role in cardio-renal homeostasis through regulation of regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, vasodilates intestinal smooth muscle but not smooth muscle strips.</text>
  </comment>
  <comment type="function">
    <molecule>Atriopeptin-2</molecule>
    <text evidence="1">May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, selectively vasodilates intestinal and vascular smooth muscle strips.</text>
  </comment>
  <comment type="function">
    <molecule>Atriopeptin-1</molecule>
    <text evidence="1">May have a role in cardio-renal homeostasis through regulation of natriuresis and vasodilation. In vivo promotes natriuresis. In vitro, selectively vasodilates intestinal smooth muscle but not vascular smooth muscle strips.</text>
  </comment>
  <comment type="subunit">
    <molecule>Atrial natriuretic peptide</molecule>
    <text evidence="30">Homodimer; disulfide-linked antiparallel dimer.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-953859">
      <id>P01160</id>
    </interactant>
    <interactant intactId="EBI-7116203">
      <id>O75031</id>
      <label>HSF2BP</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-953859">
      <id>P01160</id>
    </interactant>
    <interactant intactId="EBI-749530">
      <id>P43365</id>
      <label>MAGEA12</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-953859">
      <id>P01160</id>
    </interactant>
    <interactant intactId="EBI-741480">
      <id>Q9UMX0</id>
      <label>UBQLN1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-953859">
      <id>P01160</id>
    </interactant>
    <interactant intactId="EBI-947187">
      <id>Q9UHD9</id>
      <label>UBQLN2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="subcellular location">
    <molecule>Long-acting natriuretic peptide</molecule>
    <subcellularLocation>
      <location evidence="24 36 37 41">Secreted</location>
    </subcellularLocation>
    <text evidence="24 36 37 41">Detected in blood.</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Vessel dilator</molecule>
    <subcellularLocation>
      <location evidence="24 36 37 41">Secreted</location>
    </subcellularLocation>
    <text evidence="24 36 37 41">Detected in blood.</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Kaliuretic peptide</molecule>
    <subcellularLocation>
      <location evidence="37">Secreted</location>
    </subcellularLocation>
    <text evidence="37">Detected in blood.</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Urodilatin</molecule>
    <subcellularLocation>
      <location evidence="28 39 42 43 44 45">Secreted</location>
    </subcellularLocation>
    <text evidence="28 39 42 43 44 45">Detected in urine (PubMed:2972874, PubMed:9794555, PubMed:8351194, PubMed:8779891). Not detected in blood (PubMed:8351194). Increased electrolytes, osmolality and intracellular cAMP levels increase peptide secretion/excretion (PubMed:9893117, PubMed:8853410, PubMed:8351194, PubMed:8779891).</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Atrial natriuretic peptide</molecule>
    <subcellularLocation>
      <location evidence="8 16 24 28 36 37 39 41 42 45">Secreted</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="29">Perikaryon</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="29">Cell projection</location>
    </subcellularLocation>
    <text evidence="1 8 16 24 29 36 37 39 41 42 45">Detected in blood (PubMed:8351194, PubMed:8779891, PubMed:7955907, PubMed:8653797, PubMed:15741263, PubMed:18835931, PubMed:2532366, PubMed:7984506). Detected in urine in one study (PubMed:8351194). However, in another study, was not detected in urine (PubMed:7984506). Detected in cytoplasmic bodies and neuronal processes of pyramidal neurons (layers II-VI) (PubMed:30534047). Increased secretion in response to the vasopressin AVP (By similarity). Likely to be secreted in response to an increase in atrial pressure or atrial stretch (PubMed:2532366). In kidney cells, secretion increases in response to activated guanylyl cyclases and increased intracellular cAMP levels (PubMed:9893117). Plasma levels increase 15 minutes after a high-salt meal, and decrease back to normal plasma levels 1 hr later (PubMed:8779891).</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Atriopeptin-3</molecule>
    <subcellularLocation>
      <location evidence="1">Secreted</location>
    </subcellularLocation>
    <text evidence="1">Detected in blood. Slight increase in secretion in response to the vasopressin AVP.</text>
  </comment>
  <comment type="tissue specificity">
    <molecule>Urodilatin</molecule>
    <text evidence="28 39 40 42 44">Detected in the kidney distal tubular cells (at protein level) (PubMed:9794555, PubMed:8384600). Present in urine (at protein level) (PubMed:2972874, PubMed:9794555, PubMed:8351194, PubMed:8779891).</text>
  </comment>
  <comment type="tissue specificity">
    <molecule>Atrial natriuretic peptide</molecule>
    <text evidence="19 20 29 37 39 40 44">Detected in atrial and ventricular plasma samples, and in adipocytes (at protein level) (PubMed:22291141, PubMed:21672517). Detected in urine in one study (PubMed:8351194). However, was not detected in urine in another study (PubMed:7984506). In the brain, predominantly expressed in the gray matter with very weak expression in the white matter (at protein level) (PubMed:30534047). Localizes to astrocyte-like structures throughout the white matter, and in the cerebral vessels detected in the leptomeningeal and parenchymal vessels, and endothelium and smooth muscle layers (at protein level) (PubMed:30534047). Relatively low levels of expression in the kidneys compared to urodilatin (at protein level) (PubMed:9794555, PubMed:8384600).</text>
  </comment>
  <comment type="PTM">
    <text evidence="1 5 7 24 28 36 37 39 44">The precursor molecule is proteolytically cleaved by CORIN at Arg-123 to produce atrial natriuretic peptide (PubMed:10880574, PubMed:14559895, PubMed:7984506). Undergoes further proteolytic cleavage by unknown proteases to give rise to long-acting natriuretic peptide, vessel dilator and kaliuretic peptide (PubMed:2532366, PubMed:7955907, PubMed:7984506). Additional processing gives rise to the auriculin and atriopeptin peptides (By similarity). In the kidneys, alternative processing by an unknown protease results in the peptide urodilatin (PubMed:2972874, PubMed:8351194, PubMed:9794555).</text>
  </comment>
  <comment type="PTM">
    <molecule>Atrial natriuretic peptide</molecule>
    <text evidence="9 17 27">Cleavage by MME initiates degradation of the factor and thereby regulates its activity (PubMed:2972276, PubMed:16254193). Degraded by IDE (in vitro) (PubMed:21098034). During IDE degradation, the resulting products can temporarily stimulate NPR2 to produce cGMP, before the fragments are completely degraded and inactivated by IDE (in vitro) (PubMed:21098034).</text>
  </comment>
  <comment type="PTM">
    <molecule>Urodilatin</molecule>
    <text evidence="17">Degraded by IDE.</text>
  </comment>
  <comment type="PTM">
    <molecule>Urodilatin</molecule>
    <text evidence="23">Phosphorylation on Ser-129 decreases vasorelaxant activity.</text>
  </comment>
  <comment type="disease" evidence="22">
    <disease id="DI-04075">
      <name>Atrial standstill 2</name>
      <acronym>ATRST2</acronym>
      <description>A rare arrhythmia characterized by the absence of electrical and mechanical activity in the atria. Electrocardiographically, it is characterized by bradycardia, the absence of P waves, and a junctional narrow complex escape rhythm.</description>
      <dbReference type="MIM" id="615745"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="disease" evidence="15">
    <disease id="DI-00148">
      <name>Atrial fibrillation, familial, 6</name>
      <acronym>ATFB6</acronym>
      <description>A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure.</description>
      <dbReference type="MIM" id="612201"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="similarity">
    <text evidence="59">Belongs to the natriuretic peptide family.</text>
  </comment>
  <comment type="caution">
    <molecule>Long-acting natriuretic peptide</molecule>
    <text evidence="1 26 34">Results concerning the involvement of this peptide in blood volume and blood pressure homeostasis are conflicting. Several studies utilising in vitro and heterologous expression systems show that it is able to activate cGMP and promote vasodilation and natriuresis (PubMed:2825692, PubMed:7720651). However, an in vivo study in rat found that it is not sufficient to induce any diuretic, natriuretic, nor hypotensive responses, and is unable to bind NPR1 nor increase guanylyl cyclase activity (By similarity).</text>
  </comment>
  <comment type="caution">
    <molecule>Vessel dilator</molecule>
    <text evidence="26 33 34 35">Results concerning the involvement of this peptide in blood volume and blood pressure homeostasis are conflicting. Several studies utilising in vitro and heterologous expression systems show that it is able to activate cGMP and promote vasodilation and natriuresis (PubMed:2825692, PubMed:7720651, PubMed:7595132). However, a heterologous expression study in rat found that it is not sufficient to induce any diuretic, natriuretic, nor hypotensive responses, and is unable to bind NPR1 nor increase guanylyl cyclase activity (PubMed:7831500).</text>
  </comment>
  <comment type="online information" name="Wikipedia">
    <link uri="https://en.wikipedia.org/wiki/Atrial_natriuretic_peptide"/>
    <text>Atrial natriuretic peptide entry</text>
  </comment>
  <dbReference type="EMBL" id="K02043">
    <property type="protein sequence ID" value="AAB59379.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M30262">
    <property type="protein sequence ID" value="AAA35669.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X01470">
    <property type="protein sequence ID" value="CAA25699.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X02558">
    <property type="protein sequence ID" value="CAA25699.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X01471">
    <property type="protein sequence ID" value="CAA25700.2"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M54951">
    <property type="protein sequence ID" value="AAA35529.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M54947">
    <property type="protein sequence ID" value="AAA35529.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL021155">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="EU326308">
    <property type="protein sequence ID" value="ACA05916.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC005893">
    <property type="protein sequence ID" value="AAH05893.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="K02399">
    <property type="protein sequence ID" value="AAA35528.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="K02044">
    <property type="protein sequence ID" value="AAA51730.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS139.1"/>
  <dbReference type="PIR" id="A22693">
    <property type="entry name" value="AWHU"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_006163.1">
    <property type="nucleotide sequence ID" value="NM_006172.3"/>
  </dbReference>
  <dbReference type="PDB" id="1ANP">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=124-151"/>
  </dbReference>
  <dbReference type="PDB" id="1YK0">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.40 A"/>
    <property type="chains" value="E=129-149"/>
  </dbReference>
  <dbReference type="PDB" id="3N57">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.03 A"/>
    <property type="chains" value="C/D=124-151"/>
  </dbReference>
  <dbReference type="PDB" id="7BRH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.45 A"/>
    <property type="chains" value="L=124-151"/>
  </dbReference>
  <dbReference type="PDB" id="7BRJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="L=130-151"/>
  </dbReference>
  <dbReference type="PDB" id="7BRK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.85 A"/>
    <property type="chains" value="L=128-150"/>
  </dbReference>
  <dbReference type="PDBsum" id="1ANP"/>
  <dbReference type="PDBsum" id="1YK0"/>
  <dbReference type="PDBsum" id="3N57"/>
  <dbReference type="PDBsum" id="7BRH"/>
  <dbReference type="PDBsum" id="7BRJ"/>
  <dbReference type="PDBsum" id="7BRK"/>
  <dbReference type="AlphaFoldDB" id="P01160"/>
  <dbReference type="SMR" id="P01160"/>
  <dbReference type="BioGRID" id="110938">
    <property type="interactions" value="57"/>
  </dbReference>
  <dbReference type="IntAct" id="P01160">
    <property type="interactions" value="39"/>
  </dbReference>
  <dbReference type="STRING" id="9606.ENSP00000365663"/>
  <dbReference type="BindingDB" id="P01160"/>
  <dbReference type="ChEMBL" id="CHEMBL1293193"/>
  <dbReference type="CarbonylDB" id="P01160"/>
  <dbReference type="GlyCosmos" id="P01160">
    <property type="glycosylation" value="1 site, 1 glycan"/>
  </dbReference>
  <dbReference type="GlyGen" id="P01160">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="P01160"/>
  <dbReference type="PhosphoSitePlus" id="P01160"/>
  <dbReference type="BioMuta" id="NPPA"/>
  <dbReference type="DMDM" id="113864"/>
  <dbReference type="MassIVE" id="P01160"/>
  <dbReference type="PaxDb" id="P01160"/>
  <dbReference type="PeptideAtlas" id="P01160"/>
  <dbReference type="ProteomicsDB" id="51340"/>
  <dbReference type="Antibodypedia" id="13911">
    <property type="antibodies" value="793 antibodies from 40 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="4878"/>
  <dbReference type="Ensembl" id="ENST00000376480.7">
    <property type="protein sequence ID" value="ENSP00000365663.3"/>
    <property type="gene ID" value="ENSG00000175206.11"/>
  </dbReference>
  <dbReference type="GeneID" id="4878"/>
  <dbReference type="KEGG" id="hsa:4878"/>
  <dbReference type="MANE-Select" id="ENST00000376480.7">
    <property type="protein sequence ID" value="ENSP00000365663.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_006172.4"/>
    <property type="RefSeq protein sequence ID" value="NP_006163.1"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001ati.4">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:7939"/>
  <dbReference type="CTD" id="4878"/>
  <dbReference type="DisGeNET" id="4878"/>
  <dbReference type="GeneCards" id="NPPA"/>
  <dbReference type="HGNC" id="HGNC:7939">
    <property type="gene designation" value="NPPA"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000175206">
    <property type="expression patterns" value="Tissue enriched (heart)"/>
  </dbReference>
  <dbReference type="MalaCards" id="NPPA"/>
  <dbReference type="MIM" id="108780">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="MIM" id="612201">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="615745">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_P01160"/>
  <dbReference type="OpenTargets" id="ENSG00000175206"/>
  <dbReference type="Orphanet" id="1344">
    <property type="disease" value="Atrial standstill"/>
  </dbReference>
  <dbReference type="Orphanet" id="334">
    <property type="disease" value="Familial atrial fibrillation"/>
  </dbReference>
  <dbReference type="PharmGKB" id="PA256"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000175206"/>
  <dbReference type="eggNOG" id="ENOG502S9RQ">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000154513"/>
  <dbReference type="InParanoid" id="P01160"/>
  <dbReference type="OMA" id="GPWDASD"/>
  <dbReference type="OrthoDB" id="4309387at2759"/>
  <dbReference type="PhylomeDB" id="P01160"/>
  <dbReference type="TreeFam" id="TF106304"/>
  <dbReference type="PathwayCommons" id="P01160"/>
  <dbReference type="Reactome" id="R-HSA-2032785">
    <property type="pathway name" value="YAP1- and WWTR1 (TAZ)-stimulated gene expression"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5578768">
    <property type="pathway name" value="Physiological factors"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-977225">
    <property type="pathway name" value="Amyloid fiber formation"/>
  </dbReference>
  <dbReference type="SignaLink" id="P01160"/>
  <dbReference type="SIGNOR" id="P01160"/>
  <dbReference type="BioGRID-ORCS" id="4878">
    <property type="hits" value="12 hits in 1138 CRISPR screens"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="P01160"/>
  <dbReference type="GeneWiki" id="Atrial_natriuretic_peptide"/>
  <dbReference type="GenomeRNAi" id="4878"/>
  <dbReference type="Pharos" id="P01160">
    <property type="development level" value="Tchem"/>
  </dbReference>
  <dbReference type="PRO" id="PR:P01160"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 1"/>
  </dbReference>
  <dbReference type="RNAct" id="P01160">
    <property type="molecule type" value="Protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000175206">
    <property type="expression patterns" value="Expressed in cardiac muscle of right atrium and 148 other tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="P01160">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="Genevisible" id="P01160">
    <property type="organism ID" value="HS"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042995">
    <property type="term" value="C:cell projection"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0062023">
    <property type="term" value="C:collagen-containing extracellular matrix"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005576">
    <property type="term" value="C:extracellular region"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005615">
    <property type="term" value="C:extracellular space"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043204">
    <property type="term" value="C:perikaryon"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032991">
    <property type="term" value="C:protein-containing complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="CAFA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005179">
    <property type="term" value="F:hormone activity"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051427">
    <property type="term" value="F:hormone receptor binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005184">
    <property type="term" value="F:neuropeptide hormone activity"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071855">
    <property type="term" value="F:neuropeptide receptor binding"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005102">
    <property type="term" value="F:signaling receptor binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003180">
    <property type="term" value="P:aortic valve morphogenesis"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003161">
    <property type="term" value="P:cardiac conduction system development"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0014898">
    <property type="term" value="P:cardiac muscle hypertrophy in response to stress"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006182">
    <property type="term" value="P:cGMP biosynthetic process"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0019934">
    <property type="term" value="P:cGMP-mediated signaling"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007565">
    <property type="term" value="P:female pregnancy"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0090090">
    <property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042059">
    <property type="term" value="P:negative regulation of epidermal growth factor receptor signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043508">
    <property type="term" value="P:negative regulation of JUN kinase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003085">
    <property type="term" value="P:negative regulation of systemic arterial blood pressure"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007218">
    <property type="term" value="P:neuropeptide signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060452">
    <property type="term" value="P:positive regulation of cardiac muscle contraction"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1902261">
    <property type="term" value="P:positive regulation of delayed rectifier potassium channel activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010460">
    <property type="term" value="P:positive regulation of heart rate"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1903766">
    <property type="term" value="P:positive regulation of potassium ion export across plasma membrane"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006457">
    <property type="term" value="P:protein folding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="CAFA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007168">
    <property type="term" value="P:receptor guanylyl cyclase signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060372">
    <property type="term" value="P:regulation of atrial cardiac muscle cell membrane repolarization"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008217">
    <property type="term" value="P:regulation of blood pressure"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1902514">
    <property type="term" value="P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1901841">
    <property type="term" value="P:regulation of high voltage-gated calcium channel activity"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035994">
    <property type="term" value="P:response to muscle stretch"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0036376">
    <property type="term" value="P:sodium ion export across plasma membrane"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042311">
    <property type="term" value="P:vasodilation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="DisProt" id="DP00747"/>
  <dbReference type="InterPro" id="IPR000663">
    <property type="entry name" value="Natr_peptide"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR030480">
    <property type="entry name" value="Natr_peptide_CS"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002407">
    <property type="entry name" value="Natriuretic_peptide_atrial"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR14066">
    <property type="entry name" value="ATRIAL NATRIURETIC FACTOR PRECURSOR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR14066:SF2">
    <property type="entry name" value="NATRIURETIC PEPTIDES A"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00212">
    <property type="entry name" value="ANP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PRINTS" id="PR00711">
    <property type="entry name" value="ANATPEPTIDE"/>
  </dbReference>
  <dbReference type="PRINTS" id="PR00710">
    <property type="entry name" value="NATPEPTIDES"/>
  </dbReference>
  <dbReference type="SMART" id="SM00183">
    <property type="entry name" value="NAT_PEP"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00263">
    <property type="entry name" value="NATRIURETIC_PEPTIDE"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-1020">Atrial fibrillation</keyword>
  <keyword id="KW-0122">Cardiomyopathy</keyword>
  <keyword id="KW-0966">Cell projection</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-1015">Disulfide bond</keyword>
  <keyword id="KW-0372">Hormone</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0964">Secreted</keyword>
  <keyword id="KW-0732">Signal</keyword>
  <keyword id="KW-0838">Vasoactive</keyword>
  <keyword id="KW-0840">Vasodilator</keyword>
  <feature type="signal peptide" evidence="3">
    <location>
      <begin position="1"/>
      <end position="25"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000449721" description="Natriuretic peptides A" evidence="30">
    <location>
      <begin position="26"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449722" description="Long-acting natriuretic peptide" evidence="61 62 63">
    <location>
      <begin position="26"/>
      <end position="55"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449723" description="Vessel dilator" evidence="61 62 63">
    <location>
      <begin position="56"/>
      <end position="92"/>
    </location>
  </feature>
  <feature type="propeptide" id="PRO_0000449724" evidence="59">
    <location>
      <begin position="93"/>
      <end position="103"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449725" description="Kaliuretic peptide" evidence="60 62 63">
    <location>
      <begin position="104"/>
      <end position="123"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449726" description="Auriculin-C" evidence="1">
    <location>
      <begin position="119"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449727" description="Urodilatin" evidence="28">
    <location>
      <begin position="120"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449728" description="Auriculin-D" evidence="1">
    <location>
      <begin position="121"/>
      <end position="145"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449729" description="Atrial natriuretic peptide" evidence="5 14 30 31">
    <location>
      <begin position="124"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449730" description="Auriculin-B" evidence="1">
    <location>
      <begin position="127"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449731" description="Auriculin-A" evidence="1">
    <location>
      <begin position="127"/>
      <end position="150"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449732" description="Atriopeptin-3" evidence="1">
    <location>
      <begin position="128"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449733" description="Atriopeptin-2" evidence="1">
    <location>
      <begin position="128"/>
      <end position="150"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000449734" description="Atriopeptin-1" evidence="1">
    <location>
      <begin position="128"/>
      <end position="148"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="4">
    <location>
      <begin position="62"/>
      <end position="105"/>
    </location>
  </feature>
  <feature type="region of interest" description="Important for degradation of atrial natriuretic peptide by IDE" evidence="17">
    <location>
      <begin position="147"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="site" description="Cleavage; by CORIN" evidence="5">
    <location>
      <begin position="123"/>
      <end position="124"/>
    </location>
  </feature>
  <feature type="site" description="Cleavage; by MME" evidence="27">
    <location>
      <begin position="130"/>
      <end position="131"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="23">
    <location>
      <position position="129"/>
    </location>
  </feature>
  <feature type="disulfide bond" evidence="12 30">
    <location>
      <begin position="130"/>
      <end position="146"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_014579" description="In dbSNP:rs5063.">
    <original>V</original>
    <variation>M</variation>
    <location>
      <position position="32"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_071307" description="In ATRST2; dbSNP:rs202102042." evidence="22">
    <original>R</original>
    <variation>Q</variation>
    <location>
      <position position="150"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_082651" evidence="13 32">
    <original>Y</original>
    <variation>YRR</variation>
    <location>
      <position position="151"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of cleavage by CORIN." evidence="5">
    <original>R</original>
    <variation>G</variation>
    <location>
      <position position="123"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on degradation of atrial natriuretic peptide by IDE." evidence="17">
    <location>
      <begin position="124"/>
      <end position="129"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced degradation of atrial natriuretic peptide by IDE; when associated with N-147--151-YDEL." evidence="17">
    <location>
      <begin position="124"/>
      <end position="126"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced degradation of atrial natriuretic peptide by IDE; when associated with S-124--126-RDEL." evidence="17">
    <location>
      <begin position="147"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 6; AAA35529." evidence="59" ref="6">
    <original>E</original>
    <variation>D</variation>
    <location>
      <position position="65"/>
    </location>
  </feature>
  <feature type="strand" evidence="66">
    <location>
      <begin position="129"/>
      <end position="133"/>
    </location>
  </feature>
  <feature type="strand" evidence="65">
    <location>
      <begin position="139"/>
      <end position="141"/>
    </location>
  </feature>
  <feature type="strand" evidence="66">
    <location>
      <begin position="144"/>
      <end position="146"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="P01161"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="2">
    <source>
      <dbReference type="UniProtKB" id="P05125"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="3">
    <source>
      <dbReference type="UniProtKB" id="P24259"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="4">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="10880574"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="11145122"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="14559895"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="15741263"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="16254193"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="1660465"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="1672777"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="16870210"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="16875975"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="1826098"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="18614783"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="18835931"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="21098034"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="2162527"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="21672517"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="22291141"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="22307324"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="23275345"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="2528951"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="2532366"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="25401746"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="2825692"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="2972276"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="2972874"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="30534047"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="30">
    <source>
      <dbReference type="PubMed" id="3838202"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="31">
    <source>
      <dbReference type="PubMed" id="6230082"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="32">
    <source>
      <dbReference type="PubMed" id="6238331"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="33">
    <source>
      <dbReference type="PubMed" id="7595132"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="34">
    <source>
      <dbReference type="PubMed" id="7720651"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="35">
    <source>
      <dbReference type="PubMed" id="7831500"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="36">
    <source>
      <dbReference type="PubMed" id="7955907"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="37">
    <source>
      <dbReference type="PubMed" id="7984506"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="38">
    <source>
      <dbReference type="PubMed" id="8087923"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="39">
    <source>
      <dbReference type="PubMed" id="8351194"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="40">
    <source>
      <dbReference type="PubMed" id="8384600"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="41">
    <source>
      <dbReference type="PubMed" id="8653797"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="42">
    <source>
      <dbReference type="PubMed" id="8779891"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="43">
    <source>
      <dbReference type="PubMed" id="8853410"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="44">
    <source>
      <dbReference type="PubMed" id="9794555"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="45">
    <source>
      <dbReference type="PubMed" id="9893117"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="46">
    <source>
      <dbReference type="PubMed" id="2162527"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="47">
    <source>
      <dbReference type="PubMed" id="22291141"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="48">
    <source>
      <dbReference type="PubMed" id="2528951"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="49">
    <source>
      <dbReference type="PubMed" id="2972874"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="50">
    <source>
      <dbReference type="PubMed" id="3158606"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="51">
    <source>
      <dbReference type="PubMed" id="3838202"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="52">
    <source>
      <dbReference type="PubMed" id="6203042"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="53">
    <source>
      <dbReference type="PubMed" id="6542248"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="54">
    <source>
      <dbReference type="PubMed" id="6547996"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="55">
    <source>
      <dbReference type="PubMed" id="8087923"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="56">
    <source>
      <dbReference type="PubMed" id="8351194"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="57">
    <source>
      <dbReference type="PubMed" id="8653797"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="58">
    <source>
      <dbReference type="PubMed" id="8853410"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="59"/>
  <evidence type="ECO:0000305" key="60">
    <source>
      <dbReference type="PubMed" id="7720651"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="61">
    <source>
      <dbReference type="PubMed" id="7955907"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="62">
    <source>
      <dbReference type="PubMed" id="7984506"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="63">
    <source>
      <dbReference type="PubMed" id="8087923"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="64">
    <source>
      <dbReference type="PDB" id="3N57"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="65">
    <source>
      <dbReference type="PDB" id="1YK0"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="66">
    <source>
      <dbReference type="PDB" id="7BRH"/>
    </source>
  </evidence>
  <sequence length="151" mass="16396" checksum="F3AA066A73EC97EF" modified="2019-12-11" version="2" precursor="true">MSSFSTTTVSFLLLLAFQLLGQTRANPMYNAVSNADLMDFKNLLDHLEEKMPLEDEVVPPQVLSEPNEEAGAALSPLPEVPPWTGEVSPAQRDGGALGRGPWDSSDRSALLKSKLRALLTAPRSLRRSSCFGGRMDRIGAQSGLGCNSFRY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>